RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Regenerative Medical Technology Group Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026
- Market cap
- $497.25K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Regenerative Medical Technology's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| David Eugene Christensen CHIEF EXECUTIVE OFFICER | Aug 18, 2021 | Award | +448 | – | – | 448 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.